George N. Nikopoulos PhD, MBA
Company: Mannin Research Inc.
Job title: President & CEO
A novel ARDS therapeutic targeting the Ang1-Tie2 pathway and development of a companion diagnostic using machine learning to improve both the diagnosis and treatment of ARDS patients 9:40 am
Development of Ang1-C4bp: a novel therapeutic for ARDS The importance of Ang1-Tie2 in ARDS treatment in both COVID and non-COVID patients Collaboration between Mannin, DNAStack, Biosymmetrics to develop a novel companion diagnostic for ARDS utilizing machine learning Discussion of clinical plans and timelineRead more
day: Day One